News from The Christchurch Group
Category: Industry News
NHS England will fund everolimus for TSC-related refractory epilepsy
News from the Tuberous Sclerosis Association
People in Scotland get access to new first-in-class treatment Ocrevus®▼(ocrelizumab) for multiple sclerosis
News from industry: Roche
Encephalitis Society Silver Jubilee PhD Fellowship 2019 – Host academic Institution sought
The Encephalitis Society are seeking an academic institution to host the 2019 Encephalitis Society PhD Fellowship. Deadline: Monday, December 31, 2018
Emgality® (galcanezumab) Receives European Commission Approval for the Prophylaxis of Migraine in Adults
New migraine treatment from Lilly receives approval from European Commission
Meeting on Abeta Oligomers in Alzheimer’s Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases
Industry news from AC Immune SA
28th Alzheimer Europe Conference: Making dementia a European priority – Conference Highlights
Highlights from the Barcelona meeting
Biogen Advances Research to Improve Outcomes for Patients with Multiple Sclerosis
News from Biogen
Europe’s only medical cannabis e-learning platform announces the UK as its first learning centre launch
Free and independent platform launched
